--- title: TRC Healthcare | Insights Newsletter July 2025 description: Get the top Letter articles for July, don't miss our upcoming live CE webinars, check out the tradeshows we'll be attending this month, explore popular clinical resources, and more! --- [![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos%202022/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://trchealthcare.com/category/resources/) [![Insights: Emerging Trends for Clinical Leadership](https://info.trchealthcare.com/hs-fs/hubfs/trc_Insights_1300x300_text.png?width=1300&height=300&name=trc_Insights_1300x300_text.png) ](https://trchealthcare.com/insights-newsletter-july-2025-emerging-trends-for-clinical-leadership/) **July 2025** ### Updates You Don't Want Your Team to Miss Keep Noncontrolled Med Diversion on Your Radar ** ** Some meds that are targets for diversion are surprising. Our articles identify several of these unexpected meds along with the likely rationale for diversion. Your team can use these articles to identify potential signs of patient diversion, such as an insistence to pay cash, frequent early refills, or unusual knowledge of the medication. Similarly, we discuss behaviors that may be red flags for staff diversion such as excessive inventory restocking or unexpected stockouts. Finally, we give recommendations on how patients can prevent diversion by other household members and provide guidance on what staff should do if they suspect diversion from a team member.  **Read More:** - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2025/Jul/Keep-Noncontrolled-Med-Diversion-on-Your-Radar)  - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2025/Jul/Keep-Noncontrolled-Med-Diversion-on-Your-Radar)  - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2025/Jul/Keep-Noncontrolled-Med-Diversion-on-Your-Radar)  - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Articles/PLC/2025/Jul/Keep-Noncontrolled-Med-Diversion-on-Your-Radar)  - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2025/Jul/Keep-Diversion-of-NONcontrolled-Meds-on-Your-Radar)  - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Articles/PTLC/2025/Jul/Keep-Diversion-of-NONcontrolled-Meds-on-Your-Radar)  - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Articles/PRL/2025/Jul/Keep-Noncontrolled-Med-Diversion-on-Your-Radar)  Community Pharmacies: Shed Light on Sunscreen Rumors ** ** Questions and myths about sunscreen are common. Our articles delve into the benefits of regular sunscreen application in preventing skin carcinomas and photoaging, while addressing misconceptions about SPF levels and the safety of sunscreen ingredients. Your team can use these articles to recommend appropriate sunscreen products, educate patients on proper application techniques, and clarify the importance of sun protection for all skin types. Additionally, we discuss the impact of sunscreen on vitamin D production and provide guidance on alternative sun protection methods. For more detailed guidance, readers can review our FAQ, [*Shedding Light on Questions About Sunscreens*](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2015/Jun/Shedding-Light-on-Questions-about-Sunscreens-8524).  **Read More**:  - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2025/Jul/Shed-Light-on-Sunscreen-Rumors)  - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Articles/PLC/2025/Jul/Shed-Light-on-Sunscreen-Rumours)  - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2025/Jul/Shed-Light-on-Sunscreen-Rumors)  - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Articles/PTLC/2025/Jul/Shed-Light-on-Sunscreen-Rumours)  - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Articles/PRL/2025/Jul/Shed-Light-on-Sunscreen-Rumors)  Hospitals: Expect a Limited Role for Ceftobiprole ** ** Your team will start to get questions about ceftobiprole medocaril (Zevtera), a new IV antibiotic targeting methicillin-resistant Staph. Our article compares ceftobiprole to other antibiotics, highlighting its noninferiority in trials and similar mortality and adverse effect outcomes to ceftaroline. We also point out cost and workload considerations with ceftobiprole, along with its spectrum gaps. We tie up the article by pointing out ceftobiprole’s possible role for rare patients that need IV gram-negative plus MRSA coverage when other options can’t be used. Readers can use and share our [ceftobiprole quick skim graphic](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Jun/Ceftobiprole-Zevtera-S2506001) for dosing, administration, side effects, and more.  **Read More**:  - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2025/Jul/Expect-a-Limited-Role-for-Ceftobiprole)  - [Hospital Pharmacy Technician's Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2025/Jul/Be-Aware-of-Nuances-With-Preparing-Ceftobiprole)  ### Natural Medicines [![tianeptine](https://info.trchealthcare.com/hs-fs/hubfs/iStock-1325269497.jpg?width=771&height=452&name=iStock-1325269497.jpg) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2025/FDA-Warns-Against-Gas-Station-Heroin-Tianeptine) #### **FDA Warns Against “Gas Station Heroin” Tianeptine**  The FDA recently issued a warning about tianeptine, also known as “gas station heroin” – highlighting the risks for serious harm or death. Providers should be aware of this ingredient. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2025/FDA-Warns-Against-Gas-Station-Heroin-Tianeptine) explains what tianeptine is – an atypical antidepressant available as a prescription medication in some countries. We explain that it’s increasingly used by people seeking opioid-like effects, and that any use runs the risk of abuse, dependence, and death.  [![tianeptine](https://info.trchealthcare.com/hs-fs/hubfs/iStock-1325269497.jpg?width=771&height=452&name=iStock-1325269497.jpg) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2025/FDA-Warns-Against-Gas-Station-Heroin-Tianeptine) #### **FDA Warns Against “Gas Station Heroin” Tianeptine**  The FDA recently issued a warning about tianeptine, also known as “gas station heroin” – highlighting the risks for serious harm or death. Providers should be aware of this ingredient. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2025/FDA-Warns-Against-Gas-Station-Heroin-Tianeptine) explains what tianeptine is – an atypical antidepressant available as a prescription medication in some countries. We explain that it’s increasingly used by people seeking opioid-like effects, and that any use runs the risk of abuse, dependence, and death.  ### Pharmacy and Prescriber Podcasts #### Medication Talk Listen to this month’s podcast episode, [*Antidepressant Insights*](https://trchealthcare.buzzsprout.com/1968313/episodes/17251405-antidepressant-insights), as our expert panel discusses practical considerations for starting and optimizing antidepressants for treating depression and anxiety. You’ll listen to panelists cover various aspects of antidepressant use, such as serotonin syndrome, QT prolongation, and weight gain concerns.  All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses.   #### Rumor vs Truth [Listen to](https://trchealthcare.com/rumor-vs-truth-shedding-light-on-sunscreens/) or [watch](https://www.youtube.com/watch?v=HinPEX5wZFk) the latest episode, *Shedding Light On Sunscreens*, as two of our TRC Healthcare editors, Steven Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, and Don Weinberger, PharmD, PMSP, throw some serious shade at common sunscreen myths. Grab your shades and join our myth-busting duo as they shine a light on the facts about hot-button sunscreen claims. #### Clinical Capsules Listen to our latest episode, [*Diabetes Treatment Debate: Should Metformin Still Be Used First?*](https://trchealthcare.com/clinical-capsules-diabetes-treatment-debate-should-metformin-still-be-used-first/), as TRC Healthcare editor, Rachel Cole, PharmD**,** delves into the debate about whether newer medications for Type 2 diabetes, including SGLT-2 inhibitors or GLP-1 agonists, should be used first-line instead of metformin. She examines the benefits and drawbacks of these newer medications, including their cardiovascular and kidney benefits, side effects, and costs. ![medication talk podcast on phone with headphones ](https://info.trchealthcare.com/hs-fs/hubfs/medication%20talk%20on%20phone%20with%20headphones%20.png?width=1081&height=712&name=medication%20talk%20on%20phone%20with%20headphones%20.png) ### Upcoming Live CE Webinars for Your Clinicians #### **Mastering Meds After Acute Coronary Syndromes**  **Date: July 22 & 24, 2025**  In this month’s live webinar, [*Mastering Meds After Acute Coronary Syndromes*](https://learning.therapeuticresearch.com/course/view.php?id=6482), you’ll hear our panelists discuss the latest evidence-based recommendations for managing medications after heart attacks and other cardiac events. Listen as our panelists review which antiplatelet(s) to use and how long to use them. You’ll also hear our panelists discuss optimal blood pressure meds along with the role of statin and non-statin cholesterol meds in this population.  You can submit any questions you have [here](https://forms.office.com/pages/responsepage.aspx?id=f1DGLbaTKkCPdbsR8aUkoaJrQCZ7Qn9Dvn_LQiadLudURUpQQk5DTlBYTTlSSzgyWlZXRk1BRjFBUC4u&route=shorturl) and you may hear them answered during the webinar.    Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:  - ACCME: 1.00 hour  - ACPE: 1.00 hour – pharmacists and technicians  - ANCC: 1.00 hour [![Register Now](https://no-cache.hubspot.com/cta/default/229441/f3a355cc-24b6-4988-a6da-5a66f093e506.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/f3a355cc-24b6-4988-a6da-5a66f093e506) #### **Understanding Biosimilars: From Basics to Clinical Practice** **Date: August 19 & 21, 2025** In this month’s live webinar, [*Understanding Biosimilars: From Basics to Clinical Practice*](https://learning.therapeuticresearch.com/course/view.php?id=6560), you’ll hear our panelists discuss what biosimilars are and how to incorporate them into patient care. And you’ll listen as our panelists share practical considerations for choosing and dispensing biosimilar meds.  You can submit any questions you have [here](https://forms.office.com/r/X3tUPHDQwC) and you may hear them answered during the webinar.    Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME: - ACCME: 1.00 hour - ACPE: 1.00 hour – pharmacists and technicians - ANCC: 1.00 hour [![Register Now](https://no-cache.hubspot.com/cta/default/229441/f98ecea2-e76a-41a5-b5cd-afe0c2f767be.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/f98ecea2-e76a-41a5-b5cd-afe0c2f767be) #### Pharmacy Essential Updates  **Upcoming 2025 Live Webinars** Also, check out our upcoming [Pharmacy Essential live CE webinars](https://learning.therapeuticresearch.com/local/webinar/reports/upcoming_webinars.php). Topics include:  **July**  - Anticholinergics and new Medicare Star rating  - Diversion of non-controlled substances  - Restless legs syndrome  - NatMed Spotlight:  Panax Ginseng and Ginkgo **August**  - New drugs for migraine  - Sunscreens  - NatMed Spotlight: Tianeptine   *Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar. [![View Live CE Webinars](https://no-cache.hubspot.com/cta/default/229441/5f6625a8-59d0-4996-9efb-3f9d9a903e79.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/5f6625a8-59d0-4996-9efb-3f9d9a903e79) ## **Upcoming Tradeshows**  We have a packed tradeshow schedule this year and would love to meet with you in person! Send us a [meeting request](https://info.trchealthcare.com/sales-meeting?_gl=1*pgsv5c*_gcl_aw*R0NMLjE3NDE3MTI4NjIuRUFJYUlRb2JDaE1JLWQzOF84R0NqQU1WQmktdEJoMzBERDNLRUFBWUFTQUFFZ0ozWl9EX0J3RQ..*_gcl_au*MTE2MDYzNTMwNS4xNzM5NDc2MTMx*_ga*NDI3MzQyMzkwLjE3MDgwMTQ4NDA.*_ga_89300NMX1V*MTc0MjQ4MjA5Ny45OC4xLjE3NDI0ODI0MjIuNTIuMC4w&_ga=2.227378011.738506711.1742309035-427342390.1708014840&_gac=1.40488854.1741712862.EAIaIQobChMI-d38_8GCjAMVBi-tBh30DD3KEAAYASAAEgJ3Z_D_BwE) if you’ll be attending any of these shows. **Check out where we’ll be in the coming months: ** - AACP: July 20-21 - NACDSTSE25: August 23-25 - HCP Hospital Pharmacy Fall Reverse Expo: September 29 - October 1 - ANCC Magnet/Pathway Conference: October 8-10 [See the Full List of Events for 2025](https://trchealthcare.com/events-announcements/)  ## Popular Clinical Resources Comparison of Weight Loss Products ** ** Our popular chart compares approved weight loss products with regard to percentage of expected weight loss, dosing, cost, and other considerations.  - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2017/Jan/Comparison-of-Weight-Loss-Products-10572)  - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2017/Jan/Comparison-of-Weight-Loss-Products-10572)  - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2017/Jan/Comparison-of-Weight-Loss-Products-10572)  - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2017/Jan/Comparison-of-Weight-Loss-Products-10572)  - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2017/Jan/Comparison-of-Weight-Loss-Products-10572)  - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2017/Jan/Comparison-of-Weight-Loss-Products-10572)  - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2017/Jan/Comparison-of-Weight-Loss-Products-10572)  Sexually Transmitted Infections ** ** Our new quick reference chart outlines the recommended regimens for commonly encountered sexually transmitted infections.  - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Search/Results?search=Sexually+Transmitted+Infections&templateFilters=&segmentFilters=&dateRange=%7bCF110094-5154-4F50-881C-DDCD34E0BC04%7d&startDate=&endDate=&sortAscending=&page=1&selectedAll=&excludedSegmentTypes=%7bCF5EB270-B5AF-4518-88C5-D53022236EE2%7d%7c%7bFE309BA5-4126-4680-BEFC-4543699752DB%7d%7c%7bC856781C-B7A3-4B24-97BA-8C517F12E941%7d%7c%7b1BA3C7B2-CF19-4F64-B4FD-0CE084CFEE07%7d%7c%7b4F1913F2-83F5-47C4-AF04-11C411BD3BE0%7d%7c%7b039E4DF7-2795-4371-9E5C-2EEE8B2AC1DB%7d%7c%7b7AEC926F-ABE1-459C-984E-4C6C0CF9E301%7d%7c%7b4624FF54-026B-4114-AAC5-4CE64A3ED589%7d%7c%7bD25E8605-E9C2-4589-A2E8-5136D95810CD%7d)  - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/Sexually-Transmitted-Infections-S2505001)  - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/May/Sexually-Transmitted-Infections-S2505001)  - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/Sexually-Transmitted-Infections-S2505001) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2025/May/Sexually-Transmitted-Infections-S2505001)  HIV Postexposure Prophylaxis (PEP) Checklist ** ** Subscribers can use our updated checklist to identify when to offer PEP, what regimen to use, how to monitor patients, and more.    - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2020/Jan/HIV-Postexposure-Prophylaxis-PEP-Checklist-S2001001)  - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2020/Jan/HIV-Postexposure-Prophylaxis-PEP-Checklist-S2001001)  - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2020/Jan/HIV-Postexposure-Prophylaxis-PEP-Checklist-S2001001)  - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2020/Jan/HIV-Postexposure-Prophylaxis-PEP-Checklist-S2001001)  - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2020/Jan/HIV-Postexposure-Prophylaxis-PEP-Checklist-S2001001)  - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2020/Jan/HIV-Postexposure-Prophylaxis-PEP-Checklist-S2001001) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2020/Jan/HIV-Postexposure-Prophylaxis-PEP-Checklist-S2001001)  [![June-CP-CC-Immediate-Use-Blog](https://info.trchealthcare.com/hs-fs/hubfs/June-CP-CC-Immediate-Use-Blog.png?width=682&height=456&name=June-CP-CC-Immediate-Use-Blog.png) ](https://trchealthcare.com/the-compounding-chronicles-essential-training-and-compliance-for-immediate-use-compounding/) ### The Compounding Chronicles **Essential Training and Compliance for Immediate-Use Compounding** *By Adam West, Course and Curriculum Manager at [CriticalPoint](https://trchealthcare.com/criticalpoint/)* This month’s [Compounding Chronicles blog post](https://trchealthcare.com/the-compounding-chronicles-essential-training-and-compliance-for-immediate-use-compounding/) recaps a webinar on evolving sterile compounding regulations. As USP <797> compliance broadens, responsibilities extend to nurses, anesthesiologists, and other clinical staff. Presenters Adam West and Steve Small highlighted key updates on immediate-use compounding, contamination risks, and training—emphasizing that proper aseptic technique, role-specific SOPs, and ongoing education are essential for patient safety and compliance.   [Read the Blog](https://trchealthcare.com/the-compounding-chronicles-essential-training-and-compliance-for-immediate-use-compounding/) [![June-CP-CC-Immediate-Use-Blog](https://info.trchealthcare.com/hs-fs/hubfs/June-CP-CC-Immediate-Use-Blog.png?width=682&height=456&name=June-CP-CC-Immediate-Use-Blog.png) ](https://trchealthcare.com/the-compounding-chronicles-essential-training-and-compliance-for-immediate-use-compounding/) ### The Compounding Chronicles **Essential Training and Compliance for Immediate-Use Compounding** *By Adam West, Course and Curriculum Manager at [CriticalPoint](https://trchealthcare.com/criticalpoint/)* This month’s [Compounding Chronicles blog post](https://trchealthcare.com/the-compounding-chronicles-essential-training-and-compliance-for-immediate-use-compounding/) recaps a webinar on evolving sterile compounding regulations. As USP <797> compliance broadens, responsibilities extend to nurses, anesthesiologists, and other clinical staff. Presenters Adam West and Steve Small highlighted key updates on immediate-use compounding, contamination risks, and training—emphasizing that proper aseptic technique, role-specific SOPs, and ongoing education are essential for patient safety and compliance.   [Read the Blog](https://trchealthcare.com/the-compounding-chronicles-essential-training-and-compliance-for-immediate-use-compounding/) ### Product Spotlight #### **Now Live! Experience the New NatMed Pro Website** We’re excited to announce that the upgraded NatMed Pro platform is now live! Whether your organization already uses NatMed Pro or you're considering it for your team, you'll notice a fresh new look and design along with major performance and functionality improvements.  Designed with you in mind, the new platform offers:    - A refreshed, intuitive interface for seamless navigation   - Enhanced performance with faster load times   - Mobile-friendly design for access on any device   - Expanded database featuring over 300,000 commercial products with label images   - Improved clinical tools, including an updated Interaction Checker Tool and Effectiveness by Condition Tool   - Advanced search capabilities with added filters and sorting options  Watch a [demo webinar](https://trchealthcare.com/webinar-introducing-the-new-natmed-pro-platform-upgrade-preview/) that provides a walk-through of the new site and visit our [website upgrade overview](https://info.trchealthcare.com/now-live-natmed-pro-website) for more information on the new changes.  [![See What's New](https://no-cache.hubspot.com/cta/default/229441/62baa51b-e92e-44ac-9265-c9cd16f7e360.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/62baa51b-e92e-44ac-9265-c9cd16f7e360)   ![TRC Healthcare](https://info.trchealthcare.com/hs-fs/hubfs/_TRC%20Logos/TRC%20Healthcare/TRC%20Logo%20-%20EM.png?width=860&height=260&name=TRC%20Logo%20-%20EM.png) ##### Train Smarter. Stay Compliant with our NEW Compliance Library Compliance shouldn’t be a burden, and with our new Employer Compliance Library, it doesn’t have to be. This turnkey training solution includes 55+ expert-developed courses covering OSHA, HIPAA, FWA, ethics, dementia care, and more, designed for both clinical and non-clinical teams. Built-in assignment and tracking through the Learning Management Portal make it easy to meet CMS and state requirements across locations. Custom training options available to align with your policies and state regulations.  [ Learn More ](https://trchealthcare.com/group-purchases/employer-compliance-library/) ### **Pharmacy Law & Regulatory Update** #### Key Pharmacy Trends from the 2025 Legislative Session We know that keeping up with policy changes can be challenging, so we’ve created a concise summary of the 2025 legislative session, providing you with a quick and easy way to learn about important pharmacy-related legislative activities you may have missed. [Download the summary here.](https://info.trchealthcare.com/hubfs/Bula%20Legislative%20Session%20Summary%202025.pdf)   **Here Are the Key Highlights:**    **Prescribing and Labeling Abortifacients**  California, Colorado, Maine, New York, Pennsylvania, and Rhode Island proposed or passed legislation to allow practitioners to request the use of the name of the practice, rather than the prescriber’s name, on labels for mifepristone, misoprostol, or their generic alternatives.   **Off-label/Ivermectin Dispensing**   Multiple states, including, Georgia, Idaho, Louisiana, Maine, Minnesota, New Hampshire, North Carolina, Oklahoma, Pennsylvania, South Carolina, and Wyoming have introduced or passed legislative updates making Ivermectin available as an over-the-counter drug.  **Providing Contraceptives**  Notable proposals to contraceptive prescribing/dispensing include:   - **California**: AB 968 would allow pharmacists to furnish non-hormonal contraceptives.   - **Illinois**: If passed, SB 3489 will permit dispensing of emergency contraceptives by pharmacists.   - **Iowa**: HF 605 would allow pharmacists to dispense a 12-month supply of contraceptives via standing order.   - **South Carolina**: S 477 would authorize pharmacists to dispense self-administered hormonal contraceptives per standing order or written joint protocol.  - **Wisconsin**: If passed, AB 43 will permit a pharmacist to  - Prescribe and dispense hormonal contraceptive patches and self-administered oral hormonal contraceptives to individuals 18 years and older.  To learn more about how Bula can help keep your organization compliant, [contact us today](https://info.trchealthcare.com/bula-quote-request).   [Request Information](https://info.trchealthcare.com/bula-quote-request) [![Bula 2025 Legislative Session Summary](https://info.trchealthcare.com/hs-fs/hubfs/bula_session_summary_2025.png?width=816&height=1056&name=bula_session_summary_2025.png) ](https://info.trchealthcare.com/hubfs/Bula%20Legislative%20Session%20Summary%202025.pdf) [![Bula 2025 Legislative Session Summary](https://info.trchealthcare.com/hs-fs/hubfs/bula_session_summary_2025.png?width=816&height=1056&name=bula_session_summary_2025.png) ](https://info.trchealthcare.com/hubfs/Bula%20Legislative%20Session%20Summary%202025.pdf) ### **Pharmacy Law & Regulatory Update** #### Key Pharmacy Trends from the 2025 Legislative Session We know that keeping up with policy changes can be challenging, so we’ve created a concise summary of the 2025 legislative session, providing you with a quick and easy way to learn about important pharmacy-related legislative activities you may have missed. [Download the summary here.](https://info.trchealthcare.com/hubfs/Bula%20Legislative%20Session%20Summary%202025.pdf)   **Here Are the Key Highlights:**    **Prescribing and Labeling Abortifacients**  California, Colorado, Maine, New York, Pennsylvania, and Rhode Island proposed or passed legislation to allow practitioners to request the use of the name of the practice, rather than the prescriber’s name, on labels for mifepristone, misoprostol, or their generic alternatives.   **Off-label/Ivermectin Dispensing**   Multiple states, including, Georgia, Idaho, Louisiana, Maine, Minnesota, New Hampshire, North Carolina, Oklahoma, Pennsylvania, South Carolina, and Wyoming have introduced or passed legislative updates making Ivermectin available as an over-the-counter drug.  **Providing Contraceptives**  Notable proposals to contraceptive prescribing/dispensing include:   - **California**: AB 968 would allow pharmacists to furnish non-hormonal contraceptives.   - **Illinois**: If passed, SB 3489 will permit dispensing of emergency contraceptives by pharmacists.   - **Iowa**: HF 605 would allow pharmacists to dispense a 12-month supply of contraceptives via standing order.   - **South Carolina**: S 477 would authorize pharmacists to dispense self-administered hormonal contraceptives per standing order or written joint protocol.  - **Wisconsin**: If passed, AB 43 will permit a pharmacist to  - Prescribe and dispense hormonal contraceptive patches and self-administered oral hormonal contraceptives to individuals 18 years and older.  To learn more about how Bula can help keep your organization compliant, [contact us today](https://info.trchealthcare.com/bula-quote-request).   [Request Information](https://info.trchealthcare.com/bula-quote-request) ### About TRC Healthcare ###### TRC Healthcare provides unbiased education, training, and support to every healthcare professional to reduce knowledge gaps, encourage evidence-based practice, lower costs, and deliver better patient outcomes. ![](https://info.trchealthcare.com/hubfs/raw_assets/public/TRC/Images/logoIcon.svg) - [ Contact Us ](https://trchealthcare.com/contact-us/) - [ Privacy Policy ](https://info.trchealthcare.com/data-usage-policy) [![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://www.trchealthcare.com) © 2026 TRC Healthcare. All Rights Reserved.